Sun Life’s 2026 High-cost claims and injectable drug trends analysis – Trends, employee support, and cost management
Get a look at major high-cost claim drivers, million-dollar+ trends, and injectable drug spend insights to support benefits and stop-loss planning for self-funded employers.
Sun Life 2026 High-cost claims and injectable drug trends analysis
Thursday, June 4, 2:00–3:00 PM ET
Register for the webinar and download the report
Join Sun Life leaders to unpack what our latest claims data reveals about high-cost claim conditions, million-dollar+ volatility, and injectable drug spend, and what it means for self-funded planning.
In this webinar, we’ll cover:
- High-cost claim drivers: what’s shifting in top conditions and what million-dollar+ claims mean for volatility
- Injectable drug trends to watch, including emerging ultra-high-cost therapies
- Proactive strategies for better health outcomes, care optimization, and risk management
Speakers:
- Mike Huppert, VP, Actuarial & Risk Management, Sun Life U.S.
- Ryan Murphy, VP, Health Capabilities, Sun Life U.S.
- Miles Varn, Chief Medical Officer, Sun Life U.S.
Hosted by: Jennifer Collier, President of Health and Risk Solutions, Sun Life U.S.
Get practical takeaways to support stop-loss decisions and benefit planning.
Group stop-loss insurance policies are underwritten by Sun Life Assurance Company of Canada (Wellesley Hills, MA) in all states, except New York, under Policy Form Series 07-SL REV 7-12 and 22-SL. In New York, Group stop-loss insurance policies are underwritten by Sun Life and Health Insurance Company (U.S.) (Lansing, MI) under Policy Form Series 07-NYSL REV 7-12 and 22-NYSL. Policy offerings may not be available in all states and may vary due to state laws and regulations. Not approved for use in New Mexico.
© 2026 Sun Life Assurance Company of Canada, Wellesley Hills, MA 02481. All rights reserved. The Sun Life name and logo are registered trademarks of Sun Life Assurance Company of Canada. Visit us at www.sunlife.com/us.
GSL-SLWB-11622 #4452353131 05/26 (exp. 05/28)